Novel enzyme from LGC, Biosearch Technologies is fast and specific, even at room temperature

News - New RapiDxFire Thermostable RT delivers a novel enzyme with superior specificity, speed, and room temperature stability

07 March 2019
Edan Diagnostics acquires molecular diagnostic point of care platform from LGC

News - Edan Diagnostics, Inc., a wholly own subsidiary of Edan Instruments, Inc., a world leader in the development and manufacture of bio-electronic devices and laboratory analyzers for medical diagnostics, and LGC, a global life science tools leader, announced today the sale of LGC’s ClariLight molecular diagnostics Point of Care (POC) platform to Edan.

28 October 2019
LGC custom oligonucleotides used to develop innovative arboviruses diagnostic kit

News - Innovative kit,  recently registered with the National Health Surveillance Agency, can screen for differentiation in the same reaction on the type of dengue (1, 2, 3 or 4)

21 January 2020
LGC expedites access to its core technology to support a rapid response to the coronavirus global health emergency

News - Supporting efforts to contain virus by expediting availability of mission-critical oligo chemistries, controls and components

03 February 2020
LGC and customers expediting coronavirus diagnostic solutions

News - Working closely with customers to ensure mission-critical oligo chemistries, controls and components for detection kits are available where and when necessary

12 February 2020
LGC, Biosearch Technologies detection reagents approved by CDC for COVID-19 diagnosis

News - Testing labs can purchase approved kits from CDC-qualified lot 143503 as of today

09 March 2020
LGC expedites support to COVID-19 response efforts

News - LGC is working closely with customers and other stakeholders to support the global response to the epidemic

13 March 2020
LGC working closely with customers and partners to expedite detection solutions

News - Working together on supply of a SARS-CoV-2 assay for laboratory use which delivers a result in approximately 70 minutes

20 May 2020
LGC acquires The Native Antigen Company, strengthening its offer to the IVD sector

News - Acquisition strengthens LGC’s existing product offering to IVD sector, which includes quality assurance tools, immunoassay reagents and disease state plasma 

09 July 2020
LGC releases SARS-CoV-2 & influenza multiplexed molecular quality solutions

News - Kit designed to measure day-to-day performance of the assay providing positive and negative reference solution

29 September 2020